BIIB vs TW · P/E 21, rev $9.89B vs P/E 25, rev $1.18B
Biogen Inc (BIIB) versus Tradeweb Markets Inc (TW) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Tradeweb Markets Inc (TW) is a capital markets company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported TW revenue for 2026-06-30 was $1.18B. Net income was $386.6M. Revenue was up 90.5% from 2026-03-31 to 2026-06-30. TW currently screens at market cap $21.86B and trailing P/E 24.8.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. TW currently screens at market cap $21.86B and trailing P/E 24.8.
Not investment advice. Open the BIIB and TW stock pages for the full models.
Not investment advice.